ArticleTargeted oncology2014

Temsirolimus and pegylated liposomal doxorubicin (PLD) combination therapy in breast, endometrial, and ovarian cancer: phase Ib results and prediction of clinical outcome with FDG-PET/CT.

Marye J Boers-Sonderen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.